← Back to Search
Simultaneous Determination Of Docetaxel And Ketoconazole In Rat Plasma By Liquid Chromatography/electrospray Ionization Tandem Mass Spectrometry.
Qing Huang, G. Wang, J. Sun, Xiaolin Hu, Y. Lu, Q. Zhang
Published 2007 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
A rapid and sensitive liquid chromatography/tandem mass spectrometry (LC/MS/MS) method has been developed and validated for simultaneous quantification of docetaxel and ketoconazole in rat plasma with paclitaxel as internal standard (IS). The analytes were extracted from rat plasma by using a liquid-liquid extraction technique with ethyl acetate and the LC separation was performed on a Cosmosil-C(18) analytical column (150 mm x 2.0 mm i.d., Nacalai Tesque Inc., Japan). The extracted samples were analyzed with LC/MS/MS, operating in selected reaction monitoring (SRM) mode. The SRM transitions of precursor ions to product ions were 830.3-->549.1 (m/z) for docetaxel, 531.2-->489.3 (m/z) for ketoconazole, and 876.7-->307.9 (m/z) for the IS. The calibration curves were linear over the range of 2-500 ng/mL for docetaxel and 50-20 000 ng/mL for ketoconazole, with coefficients of correlation above 0.999. The limits of quantification for docetaxel and ketoconazole were both 2 ng/mL. The limit of detection for each analyte was 1 ng/mL. The intra- and inter-day precision (CV) of analysis were within 7%, and the accuracy ranged from 95 to 110%. The overall recoveries for docetaxel and ketoconazole were about 89.0% and 91.1%, respectively. The total analysis time was only 9.0 min. This quantitation method was successfully applied to the simultaneous determination of docetaxel and ketoconazole in rat plasma and some potential interaction was found in the current coadministration pharmacokinetic study. This established method was also utilized in the in vitro and in vivo drug-drug interaction study of docetaxel and ketoconazole (to be published).
This paper references
Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay
D. Gustafson (2003)
Clinical Pharmacokinetics of Docetaxel
S. Clarke (1999)
Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.
H. A. Bardelmeijer (2002)
Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol.
I. Ringel (1991)
Docetaxel (Taxotere): preclinical and general clinical information.
Earhart Rh (1999)
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial.
J. Nabholtz (2003)
National Cancer Institute intramural approach to advanced prostate cancer.
P. Arlen (2002)
Efficacy of microtubule-active drugs followed by ketoconazole in human metastatic prostate cancer cell lines.
M. V. Blagosklonny (2000)
The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole.
F. Odds (1980)
Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma.
R. Parise (2003)
Simple and rapid docetaxel assay in plasma by protein precipitation and high-performance liquid chromatography-tandem mass spectrometry.
W. Hou (2004)
Phase Ia study of a hypoxic cell sensitizer doranidazole (PR-350) in combination with conventional radiotherapy
K. Nemoto (2001)
Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography.
W. Loos (1997)
Determination of ketoconazole in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Yu-Luan Chen (2002)
Clinical Pharmacokinetics of Ketoconazole
T. Daneshmend (1988)
Effect of Cytochrome P450 3A4 Inhibition on the Pharmacokinetics of Docetaxel
Frederike K. Engels (2004)
A Sensitive Docetaxel Assay in Plasma by Solid-Phase Extraction and High Performance Liquid Chromatography – UV Detection: Validation and Suitability in Phase I Clinical Trial Pharmacokinetics
Claude Joseph Ardiet (2004)
Disposition of ketoconazole, an oral antifungal, in humans.
C. Brass (1982)
Ketoconazole: a novel and rapid treatment for advanced prostatic cancer.
J. Trachtenberg (1983)
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B.
D. Savarese (2001)
Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs.
I. Royer (1996)
Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.
M. Bissery (1991)
多剤耐性修飾剤バルスポダール(PSC 833)はヒトチトクロームP450 3Aにより代謝される 薬物間相互作用の関与と主代謝物の薬理活性 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター
Prediction of in vivo drug interactions with eplerenone in man from in vitro metabolic inhibition data
C. Cook (2004)
Determination of ketoconazole in the plasma, liver, lung and adrenal of the rat by high-performance liquid chromatography.
C. Riley (1986)
Simplified bioassay method for measurement of flucytosine or ketoconazole.
C. A. Bodet (1985)
Simple and sensitive high-performance liquid chromatography method for the determination of docetaxel in human plasma or urine.
M. Garg (2000)
Measurement of ketoconazole, a new antifungal agent, by high-performance liquid chromatography.
S. F. Swezey (1982)
Electrochemical detection for high-performance liquid chromatography of ketoconazole in plasma and saliva.
D. Hoffman (1988)
Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.
F. Marre (1996)
This paper is referenced by
Development and validation of a LC-MS/MS method for the determination of the novel oral 1,14 substituted taxane derivatives, IDN 5738 and IDN 5839, in mouse plasma and its application to the pharmacokinetic study.
E. Marangon (2009)
The pharmacokinetics evaluation and bioequivalence of new docetaxel injections and taxotere using healthy rats
Rong Wang (2010)
Development and Validation of a Selective and Robust LC-MS/MS Method, Employing Liquid–Liquid Extraction Based on 96-Well Format Plates, for High-Throughput Quantification of Docetaxel in Small Plasma Samples
Yiwen Wu (2009)
Quantification of taxanes in biological matrices: a review of bioanalytical assays and recommendations for development of new assays.
J. J. Hendrikx (2014)
Antineoplastic drugs and their analysis: a state of the art review.
N. Guichard (2017)
Drug–drug Interactions between Ketoconazole and Berberine in Rats: Pharmacokinetic Effects Benefit Pharmacodynamic Synergism
Y. Zhou (2012)
Development of pipette tip-based on molecularly imprinted polymer micro-solid phase extraction for selective enantioselective determination of (−)-(2S,4R) and (+)-(2R,4S) ketoconazole in human urine samples prior to HPLC-DAD
Ricky Cássio Santos da Silva (2016)
Application of validated RP-HPLC method for simultaneous determination of docetaxel and ketoconazole in solid lipid nanoparticles.
Vinay Kumar Venishetty (2011)
The Concentration of Cyclosporine Metabolites Is Significantly Lower in Kidney Transplant Recipients With Diabetes Mellitus
F. Akhlaghi (2012)
High-throughput plasma docetaxel quantification by liquid chromatography-tandem mass spectrometry.
G. Corona (2011)
Analysis of anticancer drugs: a review.
S. Nussbaumer (2011)
A UFLC-MS/MS method coupled with one-step protein precipitation for determination of docetaxel in rat plasma: comparative pharmacokinetic study of modified nanostructured lipid carrier.
Xueqiang Zhao (2013)
Stability-Indicating Validated Novel RP-HPLC Method for Simultaneous Estimation of Methylparaben, Ketoconazole, and Mometasone Furoate in Topical Pharmaceutical Dosage Formulation
C. Roy (2013)
A robust LC-MS/MS method for the simultaneous determination of docetaxel and voriconazole in rat plasma and its application to pharmacokinetic studies.
Xuexue Pei (2018)
Determination of total and unbound docetaxel in plasma by ultrafiltration and UPLC-MS/MS: application to pharmacokinetic studies
M. Sheu (2017)
LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY METHOD FOR DETERMINATION OF DOCETAXEL IN K3EDTA HUMAN PLASMA
V. J. Patro (2014)
Application of a Rapid ESI-MS/MS Method for Quantitative Analysis of Docetaxel in Polymeric Matrices of PLGA and PLGA-PEG Nanoparticles through Direct Injection to Mass Spectrometer
Pedram Rafiei (2015)
Chromatographic Methods for Determination of Drugs Used in Prostate Cancer in Biological and Pharmacological Samples
C. Saka (2019)
Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles.
Vinay Kumar Venishetty (2013)
Primena veštačkih neuronskih mreža u građenju modela za predviđanje retencionog ponašanja i intenziteta odgovora masenog spektrometra u analizi odabranih azola i sartana metodom tečne hromatografije pod visokim pritiskom
Jelena Golubović (2016)
A Critical Review of Properties and Analytical Methods for the Determination of Docetaxel in Biological and Pharmaceutical Matrices
Gilmar Hanck da Silva (2018)
A rapid and sensitive LC/ESI-MS/MS method for quantitative analysis of docetaxel in human plasma and its application to a pharmacokinetic study.
H. Yamaguchi (2012)
Development and validation of a nylon6 nanofibers mat-based SPE coupled with HPLC method for the determination of docetaxel in rabbit plasma and its application to the relative bioavailability study.
Q. Xu (2010)
Determination of main taxoids in Taxus species by microwave-assisted extraction combined with LC-MS/MS analysis.
Hao Luo (2009)
A Critical Review of Properties and Analytical Methods for the Determination of Oxytetracyline in Biological and Pharmaceutical Matrices
R. Sversut (2017)
High performance liquid chromatographic assay for the simultaneous determination of midazolam and ketoconazole in plasma.
D. Hamdy (2010)
Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer
I. Younis (2014)
A stereospecific high-performance liquid chromatographic assay for the determination of ketoconazole enantiomers in rat plasma.
D. Hamdy (2008)